Lisa Raff, PharmD

Vice President of Pharmacy Services
OneOncology

Poster(s):

• (PA-057) Outcomes of Outpatient Step-up Dosing (SUD) of Teclistamab and Talquetamab in Patients with Relapsed/refractory Multiple Myeloma (RRMM): Findings from a Large Network of Community Practices in the USA
  Friday, September 19, 2025